| Year |
Citation |
Score |
| 2011 |
Wang D, Suhrbier A, Penn-Nicholson A, Woraratanadharm J, Gardner J, Luo M, Le TT, Anraku I, Sakalian M, Einfeld D, Dong JY. A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. Vaccine. 29: 2803-9. PMID 21320541 DOI: 10.1016/J.Vaccine.2011.01.108 |
0.801 |
|
| 2010 |
Pratt WD, Wang D, Nichols DK, Luo M, Woraratanadharm J, Dye JM, Holman DH, Dong JY. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector. Clinical and Vaccine Immunology : Cvi. 17: 572-81. PMID 20181765 DOI: 10.1128/Cvi.00467-09 |
0.81 |
|
| 2009 |
Holman DH, Penn-Nicholson A, Wang D, Woraratanadharm J, Harr MK, Luo M, Maher EM, Holbrook MR, Dong JY. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity. Clinical and Vaccine Immunology : Cvi. 16: 1624-32. PMID 19776190 DOI: 10.1128/Cvi.00182-09 |
0.813 |
|
| 2009 |
Holman DH, Wang D, Woraratanadharm J, Dong JY. Viral Vectors Vaccines For Biodefense and Emerging and Neglected Diseases. 77-91. DOI: 10.1016/B978-0-12-369408-9.00007-X |
0.722 |
|
| 2008 |
Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K. A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus. Journal of Virology. 82: 6927-34. PMID 18480438 DOI: 10.1128/Jvi.02724-07 |
0.811 |
|
| 2008 |
Holman DH, Wang D, Raja NU, Luo M, Moore KM, Woraratanadharm J, Mytle N, Dong JY. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine. 26: 2627-39. PMID 18395306 DOI: 10.1016/J.Vaccine.2008.02.053 |
0.8 |
|
| 2008 |
Swenson DL, Wang D, Luo M, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clinical and Vaccine Immunology : Cvi. 15: 460-7. PMID 18216185 DOI: 10.1128/Cvi.00431-07 |
0.8 |
|
| 2007 |
Schepp-Berglind J, Luo M, Wang D, Wicker JA, Raja NU, Hoel BD, Holman DH, Barrett AD, Dong JY. Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Clinical and Vaccine Immunology : Cvi. 14: 1117-26. PMID 17634508 DOI: 10.1128/Cvi.00070-07 |
0.717 |
|
| 2007 |
Raja NU, Holman DH, Wang D, Raviprakash K, Juompan LY, Deitz SB, Luo M, Zhang J, Porter KR, Dong JY. Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector. The American Journal of Tropical Medicine and Hygiene. 76: 743-51. PMID 17426182 |
0.582 |
|
| 2007 |
Woraratanadharm J, Rubinchik S, Yu H, Dong JY. Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression. Bmc Biotechnology. 7: 9. PMID 17295927 DOI: 10.1186/1472-6750-7-9 |
0.7 |
|
| 2007 |
Holman DH, Wang D, Raviprakash K, Raja NU, Luo M, Zhang J, Porter KR, Dong JY. Two complex, adenovirus-based vaccines that together induce immune responses to all four dengue virus serotypes. Clinical and Vaccine Immunology : Cvi. 14: 182-9. PMID 17192403 DOI: 10.1128/CVI.00330-06 |
0.576 |
|
| 2007 |
RAJA NU, DONG JY, HOLMAN DH, JUOMPAN LY, PORTER KR, ZHANG J, LUO M, DEITZ SB, RAVIPRAKASH K, WANG D. INDUCTION OF BIVALENT IMMUNE RESPONSES BY EXPRESSION OF DENGUE VIRUS TYPE 1 AND TYPE 2 ANTIGENS FROM A SINGLE COMPLEX ADENOVIRAL VECTOR The American Journal of Tropical Medicine and Hygiene. 76: 743-751. DOI: 10.4269/ajtmh.2007.76.743 |
0.359 |
|
| 2006 |
Wang D, Hevey M, Juompan LY, Trubey CM, Raja NU, Deitz SB, Woraratanadharm J, Luo M, Yu H, Swain BM, Moore KM, Dong JY. Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges. Virology. 353: 324-32. PMID 16820184 DOI: 10.1016/J.Virol.2006.05.033 |
0.797 |
|
| 2006 |
Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deitz SB, Yu H, Woraratanadharm J, Holman DH, Moore KM, Swain BM, Pratt WD, Dong JY. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. Vaccine. 24: 2975-86. PMID 16530297 DOI: 10.1016/J.Vaccine.2005.11.046 |
0.804 |
|
| 2006 |
Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus. Journal of Virology. 80: 2738-46. PMID 16501083 DOI: 10.1128/Jvi.80.6.2738-2746.2006 |
0.807 |
|
| 2005 |
Dong JY, Woraratanadharm J. Gene therapy vector design strategies for the treatment of cancer. Future Oncology (London, England). 1: 361-73. PMID 16556010 DOI: 10.1517/14796694.1.3.361 |
0.705 |
|
| 2005 |
Rubinchik S, Woraratanadharm J, Yu H, Dong JY. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo. Gene Therapy. 12: 504-11. PMID 15660114 DOI: 10.1038/sj.gt.3302437 |
0.72 |
|
| 2004 |
Woraratanadharm J, Rubinchik S, Yu H, Fan F, Morrow SM, Dong JY. Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop. Gene Therapy. 11: 1399-407. PMID 15229631 DOI: 10.1038/Sj.Gt.3302307 |
0.7 |
|
| 2003 |
Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Cancer Gene Therapy. 10: 814-22. PMID 14605667 DOI: 10.1038/Sj.Cgt.7700651 |
0.702 |
|
| 2003 |
Rubinchik S, Woraratanadharm J, Schepp J, Dong JY. Improving the transcriptional regulation of genes delivered by adenovirus vectors. Methods in Molecular Medicine. 76: 167-99. PMID 12526164 DOI: 10.1385/1-59259-304-6:167 |
0.698 |
|
| Show low-probability matches. |